(MENAFN- GlobeNewsWire - Nasdaq) Opportunities center on AI and cloud platforms, real-world evidence, outsourced MSLs and medical writing, remote monitoring, and compliance support amid complex trials and infectious diseases.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Medical Affairs Outsourcing Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Medical Affairs Outsourcing Market to Reach $3.49 Billion by 2030 as Demand for Specialized Expertise Accelerates
The global medical affairs outsourcing market is experiencing rapid expansion as pharmaceutical, biopharmaceutical and medical device companies seek specialized expertise, greater operational efficiency and stronger regulatory support. The market is projected to grow from $2.07 billion in 2025 to $2.30 billion in 2026, representing a compound annual growth rate (CAGR) of 11.3%. Historical growth has been supported by increasingly complex regulatory requirements, rising clinical trial volumes, cost optimization initiatives and the continued globalization of drug development activities.
Looking ahead, the medical affairs outsourcing market is forecast to reach $3.49 billion by 2030, expanding at a CAGR of 11%. Growth during the forecast period is expected to be driven by the adoption of digital medical affairs solutions, increasing demand for real-world evidence, expanding biopharmaceutical pipelines and greater outsourcing of medical science liaison activities. Pharmaceutical companies are also placing increased emphasis on data-driven medical strategies that improve stakeholder engagement, regulatory compliance and clinical decision-making.
Key medical affairs outsourcing market trends include the growing use of external medical writing services, remote medical monitoring and cloud-based medical affairs platforms. Outsourced medical science liaison models are also gaining momentum as life sciences organizations look to extend their geographic reach while maintaining access to experienced professionals. In addition, demand for compliance, regulatory support, medical information management and scientific communications services is increasing across the healthcare sector.
The rising prevalence of infectious diseases is expected to create further opportunities for medical affairs outsourcing providers. Rapid urbanization, environmental pressures, changing lifestyles and unequal access to healthcare are contributing to higher disease burdens in several markets. Outsourcing partners support clinical trial management, regulatory compliance, scientific communication and medical information services, enabling pharmaceutical and biopharmaceutical organizations to respond more efficiently to evolving public health needs.
Recent public health data illustrates this growing demand. In February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 cases in 2022 to 4,850 in 2023. Such increases reinforce the need for effective clinical development programs, evidence generation and communication between pharmaceutical companies, healthcare professionals, regulators and other stakeholders.
Technology is becoming an important competitive factor in the medical affairs outsourcing industry. Service providers are investing in artificial intelligence, machine learning and technology-enabled platforms to strengthen data management, streamline clinical trials and support regulatory compliance. These systems can process information from multiple sources, identify emerging trends and provide insights that help organizations refine medical affairs strategies and improve stakeholder engagement.
In July 2024, Envision Pharma Group introduced 4Sight Drive, an artificial intelligence-powered platform that uses machine learning to identify trends, predict outcomes and support medical affairs decision-making. The platform processes structured and unstructured data from multiple sources, delivers client-specific insights and evolves through user feedback. Developments such as this demonstrate how digital transformation is reshaping outsourced medical affairs services and enabling more responsive, evidence-based strategies.
Strategic acquisitions are also influencing market development. In June 2023, Arterex Medical Inc. acquired NextPhase Medical Devices LLC for an undisclosed amount. The transaction was intended to strengthen Arterex Medical's multi-capability platform, increase its manufacturing and assembly capacity and expand its customer base across North America and Europe. The acquisition highlights the broader trend toward integrated service models and expanded capabilities within the medical device and medical affairs outsourcing sectors.
Medical affairs outsourcing services cover medical writing and publishing, medical monitoring, medical science liaison programs, medical information, regulatory affairs, pharmacovigilance, clinical trial support, key opinion leader management, market access support, training and education. These services are delivered through cloud-based and on-premise technology platforms and are used by pharmaceutical, biopharmaceutical and medical device organizations. By working with external specialists, life sciences companies can access targeted expertise, manage costs and focus internal resources on core research, development and commercialization priorities.
North America was the largest region in the medical affairs outsourcing market in 2025, supported by its established pharmaceutical industry, significant clinical research activity and strong demand for specialized medical services. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The market covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries included are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.
Markets Covered:
1) By Services: Medical Writing And Publishing; Medical Monitoring; Medical Science Liaisons (MSLs); Medical Information; Other Services
2) By Software: Cloud Based Software; On Premise Software
3) By Industry: Pharmaceutical; Biopharmaceutical; Medical Devices
Subsegments:
1) By Medical Writing And Publishing: Regulatory Writing; Clinical Writing; Scientific Publications; Safety Writing
2) By Medical Monitoring: On-site Monitoring; Remote Monitoring; Risk-Based Monitoring
3) By Medical Science Liaisons (MSLs): MSL Training and Development; Field Medical Support; KOL Engagement and Management
4) By Medical Information: Inquiry Management; Adverse Event Reporting; Medical Content Development
5) By Other Services: Regulatory Affairs Support; Compliance Management; Pharmacovigilance; Biostatistics And Data Management
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment